info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Edoxaban Desmethyl Impurity
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs . N-Nitroso Edoxaban Desmethyl Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Desmethyl Impurity chemically represented as N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5- nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2- carboxamido)cyclohexyl)oxalamid .Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Desmethyl Impurity. We supply N-Nitroso Edoxaban Desmethyl Impurity with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143028 |
| CAS No | NA |
| Mol.F. | C12H19N3O |
| Mol.Wt. | 221.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143029 |
| CAS No | NA |
| Mol.F. | C10H10N2O4 |
| Mol.Wt. | 222.20 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143030 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143031 |
| CAS No | NA |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143032 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143033 |
| CAS No | NA |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143034 |
| CAS No | NA |
| Mol.F. | C14H20N4O4 |
| Mol.Wt. | 308.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143035 |
| CAS No | NA |
| Mol.F. | C13H17N3O4 |
| Mol.Wt. | 279.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143036 |
| CAS No | NA |
| Mol.F. | C13H17N3O4 |
| Mol.Wt. | 279.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143037 |
| CAS No | NA |
| Mol.F. | C14H17N3O5 |
| Mol.Wt. | 307.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143038 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143039 |
| CAS No | NA |
| Mol.F. | C11H15N3O3 |
| Mol.Wt. | 237.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143040 |
| CAS No | NA |
| Mol.F. | C10H13N3O3 |
| Mol.Wt. | 223.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143041 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143042 |
| CAS No | NA |
| Mol.F. | C9H10N2O2 |
| Mol.Wt. | 178.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143043 |
| CAS No | NA |
| Mol.F. | C17H24N4O6 |
| Mol.Wt. | 380.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
